American Oriental Bioengineering, Inc. – OTC:AOBI

American Oriental Bioengineering stock price today

$0
-0.00
-40%
Financial Health
0
1
2
3
4
5
6
7
8
9

American Oriental Bioengineering stock price monthly change

+100.00%
month

American Oriental Bioengineering stock price quarterly change

+100.00%
quarter

American Oriental Bioengineering stock price yearly change

+100.00%
year

American Oriental Bioengineering key metrics

Market Cap
72.99K
Enterprise value
89.53M
P/E
N/A
EV/Sales
0.73
EV/EBITDA
-1.19
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
-755.32
Revenue
59.16M
EBITDA
-37.97M
Income
-55.13M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-74.86%
Oper. margin
-64.27%
Gross margin
32.59%
EBIT margin
-64.27%
EBITDA margin
-64.18%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

American Oriental Bioengineering stock price history

American Oriental Bioengineering stock forecast

American Oriental Bioengineering financial statements

American Oriental Bioengineering, Inc. (OTC:AOBI): Profit margin
Sep 2013 17.93M -21.17M -118.06%
American Oriental Bioengineering, Inc. (OTC:AOBI): Debt to assets
Sep 2013 427624938 143.94M 33.66%
American Oriental Bioengineering, Inc. (OTC:AOBI): Cash Flow
Sep 2013 -17.05M -13.27M 25.86M

American Oriental Bioengineering alternative data

American Oriental Bioengineering, Inc. (OTC:AOBI): Employee count
Aug 2023 3,719
Sep 2023 3,719
Oct 2023 3,719
Nov 2023 3,719
Dec 2023 3,719
Jan 2024 3,719
Feb 2024 3,719
Mar 2024 3,719
Apr 2024 3,719
May 2024 3,719
Jun 2024 3,719
Jul 2024 3,719

American Oriental Bioengineering other data

  • What's the price of American Oriental Bioengineering stock today?

    One share of American Oriental Bioengineering stock can currently be purchased for approximately $0.

  • When is American Oriental Bioengineering's next earnings date?

    Unfortunately, American Oriental Bioengineering's (AOBI) next earnings date is currently unknown.

  • Does American Oriental Bioengineering pay dividends?

    No, American Oriental Bioengineering does not pay dividends.

  • How much money does American Oriental Bioengineering make?

    American Oriental Bioengineering has a market capitalization of 72.99K.

  • What is American Oriental Bioengineering's stock symbol?

    American Oriental Bioengineering, Inc. is traded on the OTC under the ticker symbol "AOBI".

  • What is American Oriental Bioengineering's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of American Oriental Bioengineering?

    Shares of American Oriental Bioengineering can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does American Oriental Bioengineering have?

    As Jul 2024, American Oriental Bioengineering employs 3,719 workers.

  • When American Oriental Bioengineering went public?

    American Oriental Bioengineering, Inc. is publicly traded company for more then 23 years since IPO on 12 Dec 2001.

  • How can i contact American Oriental Bioengineering?

    American Oriental Bioengineering can be reached via phone at +86 10 5982 2039.

American Oriental Bioengineering company profile:

American Oriental Bioengineering, Inc.

Exchange:

OTC

Full time employees:

3,719

Industry:

Biotechnology

Sector:

Healthcare

American Oriental Bioengineering, Inc. engages in the development, manufacture, and commercialization of various pharmaceutical and healthcare products. The company primarily provides prescription pharmaceutical products, including Shuanghuanglian Lyophilized Injection Powder under the SHL brand for the treatment of flu symptoms, such as high fever, cough, and sore throat, as well as upper respiratory infections, mild pneumonia, bronchitis, and tonsillitis; and Cease Enuresis Soft Gel under the CE Gel brand to alleviate bedwetting. It also offers over-the-counter pharmaceutical products comprising Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS) and other PMS and menopause-related symptoms; and Boke Nasal Spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. In addition, the company provides various nutraceutical products, such as soybean peptide based drinks, tablets, powder, and instant coffee. Further, it is involved in the wholesale and retail of pharmaceutical and nutraceutical products. The company sells its products directly and through distributors to hospitals, clinics, pharmacies, supermarkets, fitness centers, specialty nutraceutical stores, and other retail outlets in the People's Republic of China. American Oriental Bioengineering, Inc. is headquartered in Beijing, China.

1 First Liangshuihe Avenue
Beijing, 100176

:
ISIN: US0287315032
: